Wingspire Capital Delivers $40MM Senior Secured Credit Facility to Theragenics
Wingspire Capital provided a $40 million senior secured credit facility to Theragenics, a developer and manufacturer of medical devices. The transaction included a $20 million revolving line of credit and a $20 million term loan.
November 11, 2021
David Wisen | Frank Tarallo | Theragenics | Wingspire Capital
Ian Koplin